Previous 10 | Next 10 |
CAESAREA, Israel, May 04, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical solutions to aid in the diagnosis of respiratory sleep disorders, today announced receipt of ...
Study conducted at Mount Sinai Hospital in New York City designed to demonstrate benefit of continuous positive airway pressure (CPAP) in delaying or eliminating hospitalization and/or ventilation in patients with COVID-19 Study will also evaluate obstructive sleep apnea as a risk fac...
- Company Ramping Up WatchPAT™ ONE Production Capacity to Meet Demand for Disposable Home Sleep Apnea Tests - CAESAREA, Israel, April 13, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and com...
In the best interests of retail investors with money burning holes in your pockets, let me apply a Talmudic approach to investing in the midst of a crisis; that is, consider a couple of the best functioning industries under current conditions and pinpoint individual stocks in those industries ...
Streamlining the complex process from sleep apnea diagnosis to treatment using digital health platforms meets shared mission of addressing the growing and undermanaged sleep apnea epidemic CAESAREA, Israel, April 06, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: IT...
BOSTON , March 31, 2020 /PRNewswire/ -- Lunella TM LLC launched this week, a service that simplifies and makes sleep apnea diagnosis more accessible by giving consumers an at-home alternative to the traditional in-lab sleep study as a first line diagnostic tool. In collaboratio...
CAESAREA, Israel, March 20, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today released th...
CAESAREA, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, announced today that it ...
Two additional published studies highlight WatchPAT’s accuracy and effectiveness in patients with Central Sleep Apnea (CSA) and Chronic Obstructive Pulmonary Disease (COPD) CAESAREA, Israel, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a med...
CAESAREA, Israel, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the clos...
News, Short Squeeze, Breakout and More Instantly...
- Revenues Increase d 23 % Year-over-Year to $ 13.6 Million - - U.S. WatchPAT™ Revenues Increase d 27 % Year-over-Year t o $ 11.3 ...
Shares of Itamar Medical (NASDAQ: ITMR) were skyrocketing 44.5% as of 10:48 a.m. EDT on Monday. The huge gain came after Zoll Medical, which is owned by Japanese materials science company Asahi Kasei (OTC: AHKSY) , announced plans to acquire Itamar for $538 million. The ...